Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 4, 2014, Pages 441-448

  Bachir, Bassel G ^a   Aprikian, Armen G ^a   Izawa, Jonathan I ^b   Chin, Joseph L ^b   Fradet, Yves ^c   Fairey, Adrian ^d   Estey, Eric ^d   Jacobsen, Niels ^d   Rendon, Ricardo ^e   Cagiannos, Ilias ^f   Lacombe, Louis ^c   Lattouf, Jean Baptiste ^g   Kapoor, Anil ^h   Matsumoto, Edward ^h   Saad, Fred ^g   Bell, David ^e   Black, Peter C ⁱ   So, Alan I ⁱ   Drachenberg, Darrel ^j   Kassouf, Wassim ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

Body mass index; Radical cystectomy; Radical nephroureterectomy

Indexed keywords

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLADDER CANCER; BODY MASS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADICAL RESECTION; RECURRENCE FREE SURVIVAL; URINARY TRACT CARCINOMA; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; MORTALITY; NEPHRECTOMY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE; UROLOGIC NEOPLASMS;

AGED; BODY MASS INDEX; CYSTECTOMY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UROLOGIC NEOPLASMS;

EID: 84899487486     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.10.016     Document Type: Article

References (23)

1. Wang Y., Beydoun M.A., Liang L., Caballero B., Kumanyika S.K. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008, 16:2323-2330.
2. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
3. Lowrance W.T., Thompson R.H., Yee D.S., Kaag M., Donat S.M., Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int 2010, 105:16-20.
4. Freedland S.J., Sun L., Kane C.J., et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 2008, 102:969-974.
5. Dal Maso L., Zucchetto A., Talamini R., et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008, 123:2188-2194.
6. Siegel E.M., Ulrich C.M., Poole E.M., Holmes R.S., Jacobsen P.B., Shibata D. The effects of obesity and obesity related conditions on colorectal cancer prognosis. Cancer Control 2010, 17:52-57.
7. Stewart S.B., Freedland S.J. Influence of obesity on the incidence and treatment of genitourinary malignancies. Urol Oncol 2011, 29:476-486.
8. Chang S.S., Jacobs B., Wells N., Smith J.A., Cookson M.S. Increased body mass index predicts increased blood loss during radical cystectomy. J Urol 2004, 171:1077-1079.
9. Lee C.T., Dunn R.L., Chen B.T., Joshi D.P., Sheffield J., Montie J.E. Impact of body mass index on radical cystectomy. J Urol 2004, 172:1281-1285.
10. Svatek R.S., Fisher M.B., Williams M.B., et al. Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy. Urology 2010, 76:1419-1424.
11. Hafron J., Mitra N., Dalbagni G., Bochner B., Herr H., Donat S.M. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. J Urol 2005, 173:1513-1517.
12. Maurer T., Maurer J., Retz M., et al. Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy. Urol Int 2009, 82:423-429.
13. Chromecki T.F., Cha E.K., Fajkovic H., et al. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int 2012, 21:249-255. [10.1111/j.1464-410X.2012.11322.x. Epub ahead of print].
14. Ehdaie B., Chromecki T.F., Lee R.K., et al. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol 2011, 186:66-72.
15. Inamoto T., Komura K., Watsuji T., Azuma H. Specific body mass index cut-off value in relation to survival of patients with upper urinary tract urothelial carcinomas. Int J Clin Oncol 2012, 17:256-262.
16. Yafi F.A., Aprikian A.G., Chin J.L., et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int 2011, 108:539-545. [Epub 2010 Dec 16]. 10.1111/j.1464-410X.2010.09912.x.
17. Yafi F.A., Tanguay S., Rendon R., et al. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. Urol Oncol 2013, [pii: S1078-1439(12)00407-3. Epub ahead of print]. 10.1016/j.urolonc.2012.11.014.
18. Suikkari A.M., Koivisto V.A., Rutanen E.M., Yki-Järvinen H., Karonen S.L., Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988, 66:266-272.
19. Iwamura M., Ishibe M., Sluss P.M., Cockett A.T. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol Res 1993, 21:27-32.
20. Gilbert C.A., Slingerland J.M. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 2012, [Epub ahead of print].
21. Hilmy M., Campbell R., Bartlett J.M., McNicol A.M., Underwood M.A., McMillan D.C. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer 2006, 95:1234-1238.
22. Hou C.P., Chang P.L., Chen C.L., Lin Y.H., Tsui K.H. Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. Chang Gung Med J 2001, 34:496-505.
23. Green D.A., Rink M., Xylinas E., et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 2012, [pii: S0022-5347(12)05012-4. Epub ahead of print]. 10.1016/j.juro.2012.05.079.